<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2466-1-1.anc" start="19496" end="19502" sStart="-1" offset="0" sid="null" wn="3" wnkey="show%2:32:00::" annotator="elstickles" text="Another population-based study from San Francisco &lt;b&gt;showed&lt;/b&gt; no excess of lung cancer among a cohort of men with AIDS [ 27 ] . The Italian Cooperative Study Group described 19 cases of HIV-associated lung cancer - 16 in tobacco smokers [ 28 ] . More recent studies have indicated an increase in incidence of primary lung cancer in patients with HIV infection [ 22 29 ] . Although there was no case of adenocarcinoma in the PIP study, it is the predominant cell type of bronchogenic carcinoma in patients with HIV infection [ 22 26 30 ] . The Pulmonary Complications of HIV Infection Study Group has &lt;b&gt;shown&lt;/b&gt; upper respiratory infection and bronchitis to be common in patients with HIV infection [ 3 ] . Because the PIP study included only hospitalized patients, minor respiratory problems were likely to have been ignored." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2466-1-1.anc" start="19496" end="19502" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" annotator="carichter" text="Another population-based study from San Francisco &lt;b&gt;showed&lt;/b&gt; no excess of lung cancer among a cohort of men with AIDS [ 27 ] . The Italian Cooperative Study Group described 19 cases of HIV-associated lung cancer - 16 in tobacco smokers [ 28 ] . More recent studies have indicated an increase in incidence of primary lung cancer in patients with HIV infection [ 22 29 ] . Although there was no case of adenocarcinoma in the PIP study, it is the predominant cell type of bronchogenic carcinoma in patients with HIV infection [ 22 26 30 ] . The Pulmonary Complications of HIV Infection Study Group has &lt;b&gt;shown&lt;/b&gt; upper respiratory infection and bronchitis to be common in patients with HIV infection [ 3 ] . Because the PIP study included only hospitalized patients, minor respiratory problems were likely to have been ignored." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2466-1-1.anc" start="15973" end="15978" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="comcgeetubb" text="HIV-infected individuals are highly susceptible to contracting tuberculous infection and are prone to &lt;b&gt;rapid&lt;/b&gt; evolution of active disease [ 10 ] . The rate of tuberculosis is high in African Americans and in injection drug users [ 11 ] . Although the prevalence of a positive AFB smear in patients with pulmonary MTB is approximately the same in HIV-infected and noninfected individuals, it may decline in advanced HIV-mediated immunosuppression [ 12 ] . A previous study of 133 HIV-infected adults with pulmonary MTB showed 14% of them had a normal chest radiograph [ 13 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="13880" end="13884" sStart="null" offset="498" sid="r10.high.j.0800" wn="1" wnkey="high%3:00:02::" annotator="brubin" text="Despite its decline as a result of widespread antiretroviral therapy and chemoprophylaxis, PCP has remained a common complication in patients with HIV infection [ 2 3 ] . In a prospective multicenter study of HIV seropositive patients, for 79% of those with a CD4 +lymphocyte count &lt; 200/?L receiving PCP chemoprophylaxis, the rate of first episode PCP was 3.3 per 100 person-years [ 4 ] . Although actual data were not available, high rates of noncompliance with and lack of access to antiretroviral therapy and chemoprophylaxis were likely in our study population, which included a significant number of medically underserved patients without perceived risk for HIV." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="14263" end="14267" sStart="null" offset="105" sid="r10.high.j.0574" wn="1" wnkey="high%3:00:02::" annotator="anfahmy" text="Previous studies addressed the need for simpler tests and strategies to identify patients with a high probability of having PCP to initiate either empiric treatment or aggressive investigation [ 5 6 ] . These studies reported that an increase in LDH value had variable specificity and sensitivity for the diagnosis of PCP." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="3636" end="3645" sStart="null" offset="119" sid="r8.1.different.j.0017" wn="2" wnkey="different%5:00:00:other:00" annotator="veweser" text="Multiple episodes of PCP and mycobacterial infections were defined by identifying the same organism on different admissions of the same patient." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="3636" end="3645" sStart="null" offset="119" sid="r8.1.different.j.0017" wn="4" wnkey="different%5:00:01:other:00" annotator="jeneale" text="Multiple episodes of PCP and mycobacterial infections were defined by identifying the same organism on different admissions of the same patient." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="3636" end="3645" sStart="null" offset="119" sid="r8.1.different.j.0017" wn="1" wnkey="different%3:00:00::" annotator="cgozo" text="Multiple episodes of PCP and mycobacterial infections were defined by identifying the same organism on different admissions of the same patient." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="3636" end="3645" sStart="null" offset="119" sid="r8.1.different.j.0017" wn="5" wnkey="null" annotator="brubin" text="Multiple episodes of PCP and mycobacterial infections were defined by identifying the same organism on different admissions of the same patient." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="13511" end="13517" sStart="null" offset="126" sid="r10.common.j.0793" wn="4" wnkey="common%5:00:00:familiar:02" annotator="veweser" text="Despite its decline as a result of widespread antiretroviral therapy and chemoprophylaxis, PCP has remained a common complication in patients with HIV infection [ 2 3 ] . In a prospective multicenter study of HIV seropositive patients, for 79% of those with a CD4 +lymphocyte count &lt; 200/?L receiving PCP chemoprophylaxis, the rate of first episode PCP was 3.3 per 100 person-years [ 4 ] . Although actual data were not available, high rates of noncompliance with and lack of access to antiretroviral therapy and chemoprophylaxis were likely in our study population, which included a significant number of medically underserved patients without perceived risk for HIV." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="20176" end="20182" sStart="null" offset="738" sid="r10.common.j.0876" wn="4" wnkey="common%5:00:00:familiar:02" annotator="brubin" text="Another population-based study from San Francisco showed no excess of lung cancer among a cohort of men with AIDS [ 27 ] . The Italian Cooperative Study Group described 19 cases of HIV-associated lung cancer - 16 in tobacco smokers [ 28 ] . More recent studies have indicated an increase in incidence of primary lung cancer in patients with HIV infection [ 22 29 ] . Although there was no case of adenocarcinoma in the PIP study, it is the predominant cell type of bronchogenic carcinoma in patients with HIV infection [ 22 26 30 ] . The Pulmonary Complications of HIV Infection Study Group has shown upper respiratory infection and bronchitis to be common in patients with HIV infection [ 3 ] . Because the PIP study included only hospitalized patients, minor respiratory problems were likely to have been ignored." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="317" end="323" sStart="null" offset="274" sid="r10.common.j.0490" wn="2" wnkey="common%3:00:01::" annotator="anfahmy" text="Since the beginning of the acquired immunodeficiency syndrome (AIDS) epidemic, pulmonary complications have been major causes of morbidity and mortality in patients with human immunodeficiency virus (HIV) infection [ 1 ] . In addition to the common pulmonary diseases affecting immunocompetent individuals, HIV seropositive patients are prone to other infectious and noninfectious complications." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-1-1.anc" start="2485" end="2490" sStart="null" offset="59" sid="r10.board.n.0558" wn="1" wnkey="board%1:14:00::" annotator="anfahmy" text="The study was approved by the Institutional Review Board of the hospital, which waived the need for informed consent." />
  </sentences>
</list>